Sharenet Sites 
Sharenet Sites
Brimstone acquires control of Obsidian Health
Brimstone Investment Corporation Limited
(Incorporated in the Republic of South Africa)
Registration number 1995/010442/06
ISIN Number: ZAE000015277 Share Code: BRT
ISIN Number: ZAE000015285 Share Code: BRN
(“Brimstone”)
BRIMSTONE ACQUIRES CONTROL OF OBSIDIAN HEALTH
Brimstone today announced that it acquired a further 55% stake in Obsidian Health, increasing
its total shareholding to 80%. This stake was acquired for a cash consideration of R35.7million.
All conditions precedent have been met and the transaction has been concluded.
Obsidian Health is a leading supplier of innovative healthcare solutions to both the private and
public healthcare sectors within Sub-Saharan Africa. The product portfolio includes capital
equipment and medical devices within the key focus areas of Cardiology, Cardiovascular,
Theatre, ICU and High Care, Orthopaedics as well as Point of Care (POC) diagnostic testing.
Obsidian Health has long term partnerships with a number of gold standard multinational
healthcare companies within Sub-Saharan Africa.
Obsidian Health is the exclusive distributor of trusted specialist healthcare brands such as
Ansell, Abbott Point of Care, Erbe, Serres, Integra Life Sciences, and AE Medical.
Obsidian Health is the remaining portion of the medical division of The Scientific Group, in
which Brimstone was an investor for close to 20 years. Brimstone has a long-term partnership
approach to its investments - this model has delivered real shareholder value while advancing
effective transformation and inclusive empowerment.
Mustaq Brey, Chief Executive Officer of Brimstone says, “We have walked a long road with a
strong management team in Obsidian Health. This is another example of how we have
increased our stake over time to a very meaningful position in a good business. The acquisition
is in line with our strategy of having control or significant influence and increasing our portfolio
of unlisted assets. Having been invested in this business for a very long time, we have a deep
understanding of the dynamics and metrics of this business, and will continue to add value
and benefit Obsidian Health with our strong empowerment credentials.”
Shawn Landman, Chief Executive Officer of Obsidian Health says, “Brimstone has played a
significant role in Obsidian’s growth over the years. Now as our majority shareholder we look
forward to further enhancing that relationship with our ability in attracting global multinational
healthcare partners. Obsidian Health is committed to providing cost effective and innovative
healthcare solutions to the local market in our efforts to provide healthcare access to all.”
Cape Town
10 February 2020
Investment Bank, Corporate Advisor and Sponsor
Nedbank Corporate and Investment Banking
Date: 10-02-2020 09:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
